ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RSLS ReShape Lifesciences Inc

0.1722
-0.0031 (-1.77%)
Last Updated: 11:40:04
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
ReShape Lifesciences Inc RSLS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0031 -1.77% 0.1722 11:40:04
Open Price Low Price High Price Close Price Previous Close
0.175 0.1687 0.179 0.1753
more quote information »

Recent News

Date Time Source Heading
4/01/202415:05GLOBEReShape Lifesciences® Reports Year Ended December 31, 2023..
3/28/202407:31GLOBEReShape Lifesciences® Receives Notice of Allowance for..
3/04/202407:31GLOBEReShape Lifesciences® Provides Update on 2024 Cost Reduction..
2/26/202415:19EDGAR2Form 8-K - Current report
2/22/202407:31GLOBEReShape Lifesciences® Announces First Surgeries Utilizing..
1/24/202407:31GLOBEReShape Lifesciences® Conducts Bariatric Fellows Training..
1/18/202415:38EDGAR2Form 8-K - Current report
1/16/202417:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/05/202415:14EDGAR2Form PRE 14A - Other preliminary proxy statements
12/20/202307:31GLOBEReShape Lifesciences® Engages Maxim Group LLC To Identify..
12/12/202315:05GLOBEReShape Lifesciences® Receives FDA PMA Supplement Approval..
11/29/202315:05EDGAR2Form 8-K - Current report
11/21/202307:06GLOBEReShape Lifesciences® Enters into Warrant Exercise..
11/08/202315:05GLOBEReShape Lifesciences® Reports Third Quarter Ended September..
11/06/202307:31GLOBEReShape Lifesciences® to Announce Financial Results for the..
10/13/202315:42EDGAR2Form 8-K - Current report
10/05/202315:05EDGAR2Form 8-K - Current report
10/03/202308:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
9/29/202311:30GLOBEReShape Lifesciences® Announces Pricing of $3.0 Million..
9/27/202316:30EDGAR2Form S-1/A - General form for registration of securities..
9/22/202315:02EDGAR2Form 8-K - Current report
9/22/202307:31GLOBEReShape Lifesciences® Announces Participation in the LD..
9/21/202307:31GLOBEReShape Lifesciences® Signs Exclusive License Agreement With..
9/19/202307:31GLOBEReShape Lifesciences® Significantly Strengthens Patent..
9/14/202307:31GLOBEReShape Lifesciences® Receives NIH SBIR Grant to Further..
8/25/202315:41EDGAR2Form S-1 - General form for registration of securities under..
8/07/202316:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202315:54EDGAR2Form 8-K - Current report
8/07/202315:05GLOBEReShape Lifesciences® Reports Second Quarter Ended June 30,..
8/03/202315:05GLOBEReShape Lifesciences® to Announce Financial Results for the..
6/29/202307:31GLOBEReShape Lifesciences® Signs Preferred Partner Agreement With..
6/28/202307:31GLOBEReShape Lifesciences® Presents Data on its Proprietary..
6/26/202315:05GLOBEReShape Lifesciences® Submits FDA PMA Supplement Application..
6/23/202307:35GLOBELife Science Investor Forum: Presentations Now Available for..
6/20/202309:58GLOBELife Science Investor Forum Agenda Announced for June 22nd
6/14/202307:31GLOBEReShape Lifesciences® to Participate in Investor and..
5/15/202315:05GLOBEReShape Lifesciences® Reports First Quarter Ended March 31,..
5/11/202307:30GLOBEReShape Lifesciences® to Announce Financial Results for the..

Your Recent History

Delayed Upgrade Clock